Home » Stocks » IBER

Ibere Pharmaceuticals (IBER)

Stock Price: $9.67 USD -0.03 (-0.31%)
Updated Jun 22, 2021 4:00 PM EDT - Market closed
Market Cap 140.22M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 14.50M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day June 22
Last Price $9.67
Previous Close $9.70
Change ($) -0.03
Change (%) -0.31%
Day's Open 9.70
Day's Range 9.67 - 9.71
Day's Volume 1,106
52-Week Range 9.65 - 9.95

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

PHILADELPHIA, May 28, 2021 /PRNewswire/ -- Ibere Pharmaceuticals (NYSE: IBER) (the "Company") today announced that it received a notice on May 25, 2021 from the New York Stock Exchange (the "NYSE") indi...

3 weeks ago - PRNewsWire

Ibere Pharmaceuticals (the "Company") announced today that it closed its initial public offering of 13,800,000 units at $10.00 per unit, which...

3 months ago - PRNewswire

Ibere Pharmaceuticals, a blank check company formed by PIPV Capital targeting pharmaceutical or life science businesses, filed on Tuesday with the SEC to raise up to $100 million in an initial public of...

4 months ago - NASDAQ

Ibere Pharmaceuticals has filed to go public with an IPO on the New York Stock Exchange (NYSE).

4 months ago - SEC

About IBER

Ibere Pharmaceuticals is a blank check company whose business purpose is to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Ibere Pharmaceuticals is targeting a large addressable market as total worldwide prescription drug sales lost due to patent expiration from 2020 through 2026 is expected to be approximately $252 billion, according to EvaluatePharma. Our management team has a combined track record of over 100 years of successfully identifying, ac... [Read more...]

Industry
Shell Companies
IPO Date
Feb 26, 2021
CEO
Osagie Imasogie
Country
United States
Stock Exchange
NYSE
Ticker Symbol
IBER
Full Company Profile